Navigation Links
Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
Date:2/27/2008

LITTLE ROCK, Ark., Feb. 27 /PRNewswire/ -- Cauley Bowman Carney & Williams, PLLC announces an investigation into the proposed acquisition of CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI). On February 26, 2008, CollaGenex announced that it has entered into a definitive merger agreement with an affiliate of Galderma Pharma S.A. Under the terms of the proposal, CollaGenex's shareholders would receive $16.60 per share in cash for each share owned. This price per share represents an approximately 33% premium over the stock's closing price of $16.23 prior to announcement of the acquisition.

Cauley Bowman Carney & Williams, PLLC

Cauley Bowman is a national law firm that represents investors in securities fraud and corporate governance class actions. It is one of the country's premier firms in the area of securities fraud having recovered billions of dollars for defrauded investors and secured significant corporate governance reforms. Cauley Bowman maintains in-house finance, forensic accounting specialists and extensive trial experience.

If you are a current shareholder of CollaGenex Pharmaceuticals, Inc. and would like to be advised of your rights in this matter, you may contact Cauley Bowman Carney & Williams, PLLC at the phone number below.

CONTACT

Darrin L. Williams, Esq.

Randall K. Pulliam, Esq.

Kristi Gray

501-312-8500

1-888-551-9944

info@cauleybowman.com


'/>"/>
SOURCE Cauley Bowman Carney & Williams, PLLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. DuPont Leaders Brief Investors on Agriculture Businesses
3. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
4. Thermo Fisher Scientific to Present at Investor Conferences
5. Modigene to Present at the Roth 2007 New York Investor Conference
6. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
9. Suntech to Attend Upcoming Investor Conferences and Industry Events
10. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
11. American Oriental Bioengineering Announces Participation in September Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):